Wednesday, May 10
4:00 pm - 7:00 pm
Gilead
•
Since 1987, Gilead Science’s more than 16,000 employees have been committed to bringing forward medicines able to address unmet medical needs in virology, oncology and inflammation.
Join TriangleCIO member Marc Berson to explore the technologies driving Gilead’s creation of more than 25 innovative medicines, helping to transform treatment for diseases such as HIV, viral hepatitis, and cancer.